Inhibition of topoisomerase IIα sensitizes FaDu cells to ionizing radiation by diminishing DNA repair
- 17 June 2015
- journal article
- Published by Springer Nature in Tumor Biology
- Vol. 36 (11) , 8985-8992
Abstract
Despite the high efficiency of ionizing radiation (IR) to inactivate malignant tumours in general, an appreciable number of individual patients cannot be cured by standard IR. Head and neck tumours are not likely to be cured even by high-dose radiotherapy or chemotherapy. Accordingly, combined therapy is one of the most applicable strategies. Topoisomerase IIα is a ubiquitous enzyme that removes knots and tangles from the genetic material by generating and subsequently resealing of transient double-strand breaks. Due to its unique mechanism of action, topoisomerase IIα is the target of many chemotherapeutic agents such as etoposide. The aim of the present study is to examine the effect of inhibiting topoisomerase IIα by etoposide on the response of squamous cell carcinoma to IR. Results of the present study demonstrated a radiosensitizing effect for the topoisomerase IIα inhibitor etoposide on exponentially growing squamous cell carcinoma (FaDu) cell line especially at low radiation doses. This effect was found to be due to inhibition, by etoposide, of the repair of radiation-induced DNA damage. Cell cycle studies showed that the concentration of etoposide that sensitized the cells to radiation had no effect on the distribution of cells at different phases of the cell cycle. Synchronization of FaDu cells in different cell cycle phases revealed that proliferating G1 and G2 cells are responsible for sensitization of cells at low doses of ionizing radiation. It might, therefore, be concluded that topoisomerase II enzyme may be involved in the repair of radiation-induced DNA damage and consequently its inhibition constitute a strategy for sensitizing tumour cells to ionizing radiation.Keywords
This publication has 30 references indexed in Scilit:
- Modulation of radiation response by inhibiting topoisomerase II catalytic activityMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2006
- The cell cycle phases of DNA damage and repair initiated by topoisomerase II-targeting chemotherapeutic drugsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2005
- Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage CheckpointsAnnual Review of Biochemistry, 2004
- Role of p53 mutations, protein function and DNA damage for the radiosensitivity of human tumour cellsInternational Journal of Radiation Biology, 2004
- Pathways of DNA Double-Strand Break Repair during the Mammalian Cell CycleMolecular and Cellular Biology, 2003
- Effects of cell cycle phase on low-dose hyper-radiosensitivityInternational Journal of Radiation Biology, 2003
- Cellular roles of DNA topoisomerases: a molecular perspectiveNature Reviews Molecular Cell Biology, 2002
- Ionizing radiation damage repair: a role for topoisomerases?Mutagenesis, 2001
- Cell-cycle regulation of the DNA topoisomerase IIα promoter is mediated by proximal CCAAT boxes: possible involvement of acetylationGene, 2000
- Recurrent brainstem gliomas treated with oral VP-16Journal of Neuro-Oncology, 1993